Phase transition of the monotonicity assumption in learning local average treatment effects
Yinchu Zhu

TL;DR
This paper investigates the sensitivity of the monotonicity assumption in LATE estimation, revealing a phase transition where small violations can drastically affect the ability to identify the sign of the treatment effect.
Contribution
It characterizes the phase transition boundary for the monotonicity assumption and proposes simple alternatives, enhancing understanding of when LATE identification is feasible.
Findings
A phase transition boundary is explicitly characterized.
Learning the sign of LATE is impossible on one side of the boundary.
Testing the monotonicity assumption is feasible in specific cases with near one-sided non-compliance.
Abstract
We consider the setting in which a strong binary instrument is available for a binary treatment. The traditional LATE approach assumes the monotonicity condition stating that there are no defiers (or compliers). Since this condition is not always obvious, we investigate the sensitivity and testability of this condition. In particular, we focus on the question: does a slight violation of monotonicity lead to a small problem or a big problem? We find a phase transition for the monotonicity condition. On one of the boundary of the phase transition, it is easy to learn the sign of LATE and on the other side of the boundary, it is impossible to learn the sign of LATE. Unfortunately, the impossible side of the phase transition includes data-generating processes under which the proportion of defiers tends to zero. This boundary of phase transition is explicitly characterized in the case of…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Statistical Methods and Inference · Statistical Methods in Clinical Trials
